NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BRT Biotechnologies

BRT Biotechnologies

Private
Claremont, CaliforniaHealthcare & Life Scienceshttps://brtbio.com/

Last Round

Seed Round

May 8, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BRT Biotechnologies is a discovery tools company that operates a platform to generate diverse and high-quality macrocyclic compounds for drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

macrocycle drug discoverymacrocyclic compoundsdrug discovery platformmacrocycle librariesundruggable targetscontract research organizationCROhard-to-drug targetsdrug discovery servicesmacrocycle synthesisprotein-protein interactionsPPI inhibitorshit-to-lead optimizationchemical librariesmacrocyclic peptide librariesMCP libraries

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BRT Biotechnologies Comparables

Compare BRT Biotechnologies with similar companies based on industry and business-model similarity.

BRT Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

BRT Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMay 8, 2026
AcceleratorOct 26, 2022

Key People

Founding team and executive leadership

Jane Liu

CEO And Co-Founder

Founding Team

BRT Biotechnologies Investors

Notable investors and investment history

BRT Biotechnologies investors
InvestorRounds
StoryHouse VenturesSeed Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 8, 2026

    $607K raised in Seed Round.

  • Jan 2, 2026

    Monthly visitors grew 1378% MoM, from 36 to 532.

BRT Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BRT Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BRT Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersClaremont, California
Employee Range8
Year Founded2021
Last FundingMay 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.